Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.

Clinical laboratory - 1 Jan 2023

Habibnia Shadi, Karami-Zarandi Morteza, Zaker Saeed, Ghalavand Zohreh, Doustdar Farahnoosh, Eslami Gita, Kazemian Hossein

Abstract excerpt

BACKGROUND: The emergence of multidrug resistance and extensively drug-resistant tuberculosis is a serious public health crisis. Using rapid and inexpensive molecular methods such as HRM assay in the detection of second-line drugs resistance in M. tuberculosis would be helpful in the treatment and control of XDR tuberculosis cases. METHODS: MDR-TB isolates were collected from Iranian tuberculosis laboratories....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amikacin
Share to Antitubercular Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple, Bacterial

Share to Extensively Drug-Resistant Tuberculosis

Share to Kanamycin

Share to Mycobacterium tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 36649505
DOI: 10.7754/Clin.Lab.2022.220211

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis.PMID 36649505Read ↗

Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.Semantic proximity Read ↗

Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China.Semantic proximity Read ↗

Characterization of resistance mutations against first and second line antituberculosis drugs of multi-drug resistant Mycobacterium tuberculosis strains isolated from clinical samples by In house PCR method and comparison of resistance profilesSemantic proximity Read ↗

Molecular characterisation of mutations associated with resistance to first- and second-line drugs among Indonesian patients with tuberculosisSemantic proximity Read ↗

Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study.Semantic proximity Read ↗

Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil.Semantic proximity Read ↗

Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.Semantic proximity Read ↗

Analysis of drug resistance and mutation profiles in Mycobacterium tuberculosis isolates in a surveillance site in Beijing, China.Semantic proximity Read ↗

Prevalence and risk factors of drug-resistant tuberculosis in border provinces of Iran.Semantic proximity Read ↗

Molecular characterization of mutations associated with resistance to second line drugs in Mycobacterium tuberculosis patients from Casablanca, Morocco.Semantic proximity Read ↗

Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.Semantic proximity Read ↗

Rapid molecular screening for multidrug-resistant tuberculosis in a resource-limited region of China.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.